Abstract
In sub-Saharan Africa, HIV/AIDS remains a leading cause of death. The UNAIDS established the “95-95-95” targets to improve HIV care continuum outcomes. Using geospatial data from the Zambia Population-based HIV Impact Assessment (ZAMPHIA), this study aims to investigate geospatial patterns in the “95-95-95” indicators and individual-level determinants that impede HIV care continuum in vulnerable communities, providing insights into the factors associated with gaps. This study used data from the 2016 ZAMPHIA to investigate the geospatial distribution and individual-level determinants of engagement across the HIV care continuum in Zambia. Gaussian kernel interpolation and optimized hotspot analysis were used to identify geospatial patterns in the HIV care continuum, while geospatial k-means clustering was used to partition areas into clusters. The study also assessed healthcare availability, access, and social determinants of healthcare utilization. Multiple logistic regression models were used to examine the association between selected sociodemographic and behavioral covariates and the three main outcomes of study. Varied progress towards the “95-95-95” targets were observed in different regions of Zambia. Each “95” displayed a unique geographic pattern, independent of HIV prevalence, resulting in four distinct geographic clusters. Factors associated with gaps in the “95s” include younger age, male sex, and low wealth, with younger individuals having higher odds of not being on ART and having detectable viral loads. Our study revealed significant spatial heterogeneity in the HIV care continuum in Zambia, with different regions exhibiting unique geographic patterns and levels of performance in the “95-95-95” targets, highlighting the need for geospatial tailored interventions to address the specific needs of different subnational regions. These findings underscore the importance of addressing differential regional gaps in HIV diagnosis, enhancing community-level factors, and developing innovative strategies to improve local HIV care continuum outcomes.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
Research reported in this publication was supported by the National Institute of Mental Health and the National Institute of Allergy and Infectious Diseases of the National Institutes of Health under award numbers 5R01MH124478 and 1R01AI174932. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Data are available in a public, open-access repository. The data that support the findings of this study are available from the Population-Based HIV Impact Assessment (PHIA; https://phia-data.icap.columbia.edu/). Human subjects and ethical approval for the ZAMPHIA survey was granted by the Zambia National Health Research Ethics Board, the Tropical Diseases Research Centers Ethics Review Committee, and the Institutional Review Boards at the Centers for Disease Control and Prevention (CDC; Atlanta, Georgia, USA). All participants provided written informed consent or assent for the original survey.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
Data are available in a public, open-access repository. The data that support the findings of this study are available from the Population-Based HIV Impact Assessment (PHIA; https://phia-data.icap.columbia.edu/), but restrictions apply to the availability of these data, which were used under license for the current study and so are not publicly available. We sought and were granted permission to use the core data set for this analysis by PHIA.
